Dyne Therapeutics, Inc.
(DYN - NASDAQ)
18,04 USD
📋 Profilo Aziendale

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States.

|